
HealthBreakthroughs
MIT engineers have developed an ultrasound wearable pacemaker sticker that corrects heart arrhythmias without surgery, published in Nature Biomedical Engineering.
Three million adults in the United States live with a pacemaker stitched into their chest. The device works reliably, but the implantation procedure involves threading wires through a vein and into the heart, with all the infection risks and recovery time that entails. A team at MIT thinks the next generation could skip the surgery entirely.
Their ultrasound wearable pacemaker, described in Nature Biomedical Engineering on 2 June 2026, is a sticker roughly the size of a postage stamp. Worn on the chest, it fires precisely timed ultrasound pulses through skin, muscle, and bone to pace the heart from outside the body.
The trick lies in getting heart cells to respond to sound. Ultrasound passes harmlessly through the body every day in hospital scanning rooms, but the cardiac muscle does not normally respond to it with any useful force. Professor Xuanhe Zhao’s group at MIT solved this with sonogenetics. This technique genetically modifies specific ion channels in heart cells so they open more readily when hit by ultrasound waves.
In the team’s vision for clinical use, a patient would receive a one-time injection, a form of gene therapy similar to treatments the US Food and Drug Administration already approves for conditions such as sickle cell disease. That injection would sensitise cardiac cells to the pacemaker’s frequencies. From then on, the sticker handles the rest.
When the transducers fire, ultrasound waves pass through the chest and cause the modified ion channels to open, allowing calcium to flood into the cell. Calcium is the chemical trigger that tells a heart cell to contract. By timing the pulses, the sticker can set a steady rhythm, speeding up a heart that beats too slowly or correcting one that beats erratically.
In lab experiments, the team applied pulses to engineered human cardiac cells and watched them contract in lockstep with the ultrasound. In rats, the sticker corrected arrhythmias and restored normal sinus rhythm within seconds. “We can now use low-intensity ultrasound to open ion channels in cells to have very effective heart pacing,” said Chen Gong, the study’s first author.
The prototype pairs the sticker with a pocket-sized unit containing batteries and electronics. Zhao’s group had previously demonstrated an ultrasound sticker that images deep organs. They now plan to combine imaging and stimulation into a single device, creating a closed-loop system that monitors the heart continuously and intervenes only when needed.
Engineering deep dive
The engineering here bridges mechanical engineering, biomedical engineering, and genetics, a combination that would have seemed unlikely even a decade ago.
Start with the physics. Ultrasound consists of pressure waves at frequencies above 20 kHz, beyond human hearing. Medical ultrasound typically operates between 1 and 15 MHz. At these frequencies, waves propagate through soft tissue with relatively little attenuation, which is why ultrasound imaging works so well for scanning organs deep inside the body. The pacemaker sticker operates at the lower end of this range, where penetration depth is greatest, allowing the pulses to reach the heart through several centimetres of chest wall.
The transducers themselves are piezoelectric elements, crystals that deform when voltage is applied and vibrate at the desired frequency. Students who have covered piezoelectricity in A-level Physics will recognise the inverse piezoelectric effect at work. The sticker embeds an array of these elements into a hydrogel adhesive layer that Zhao's group has refined over several years. The hydrogel serves two purposes: it bonds strongly to skin, and its acoustic impedance closely matches that of human tissue, minimising reflections at the skin surface and ensuring maximum energy transfer into the body.
The biological innovation, sonogenetics, borrows from optogenetics, a Nobel Prize-winning technique that makes neurons fire in response to light. Optogenetics requires fibre-optic cables implanted in the brain. Sonogenetics replaces light with sound, which penetrates tissue without any implant.
The team modified a specific mechanosensitive ion channel, a protein embedded in the cell membrane that acts as a gate. Normally, these channels respond to membrane stretching. The genetic modification lowers their activation threshold, so that the mechanical vibrations from ultrasound are sufficient to force them open. When they open, calcium ions (Ca2+) rush into the cell down their concentration gradient, a process A-level Biology students will recognise as facilitated diffusion through gated channels. The influx of calcium triggers the contractile machinery of the cardiac myocyte, the actin-myosin sliding filament mechanism, producing a heartbeat.
The closed-loop concept the team is pursuing adds another layer of engineering. Ultrasound imaging uses the same transducers in receive mode, listening for echoes rather than transmitting pulses. By alternating rapidly between transmit and receive, a single sticker could image the heart's motion, detect when the rhythm drifts, and deliver a corrective pulse within milliseconds. This is feedback control applied to biology, a concept familiar from A-level control systems in Design and Technology.
The clinical pathway involves a form of gene therapy using adeno-associated virus (AAV) vectors, the same delivery system approved for treatments such as Luxturna (for inherited blindness) and Zolgensma (for spinal muscular atrophy). The AAV carries the genetic instructions for the modified ion channels into cardiac cells, where they integrate and begin producing the sensitised channel proteins. This is a one-time procedure, and the modified channels remain functional for the life of the cell.
Manufacturing the sticker at scale presents its own challenges. Each piezoelectric element must be precisely positioned and acoustically coupled to the hydrogel layer. The electronics must be miniaturised to a wearable form factor while maintaining sufficient power output to drive the transducers. The team's current prototype uses an external battery pack, but future versions could integrate flexible batteries or energy-harvesting circuits.
Links to the curriculum: A level, GCSE
Human trials remain some years away, and the gene therapy component will face its own regulatory hurdles. But the principle, pacing a heart with sound waves and a sticker rather than implanted hardware, has now been demonstrated in living animals. If it translates, the three million Americans with pacemakers, and the surgeons who implant them, will be watching closely.
Credit via news.mit.edu